Brief: Beyond Air Announces Positive Data From At-Home Pilot Study In Patients With Refractory NTM Lung Infection

Beyond Air

17/10/2022 21:25

Oct 17 (Reuters) - Beyond Air Inc  XAIR.O :
    * BEYOND AIR® ANNOUNCES POSITIVE DATA FROM AT-HOME PILOT
STUDY IN
PATIENTS WITH REFRACTORY NTM LUNG INFECTION TREATED WITH (NO)
USING THE LUNGFIT® GO AT THE CHEST ANNUAL MEETING 2022
    * BEYOND AIR INC - DATA SHOW FAVORABLE SAFETY, TOLERABILITY,
AND
EFFICACY RESULTS
    * BEYOND AIR INC - ALL PATIENTS TITRATED TO 250 PPM NO WITH
NO
PATIENTS NEEDING TO REDUCE CONCENTRATION
    * BEYOND AIR INC - LL PATIENTS DEMONSTRATED ABILITY TO
SELF-ADMINISTER NO AT HOME USING EASY-TO-OPERATE AND COMPACT
NOVEL NO GENERATOR, LUNGFIT GO

Source text for Eikon:  ID:nGNX55FDgN 
Further company coverage:  XAIR.O 
 ((Reuters.Briefs@thomsonreuters.com;))